![]() |
Volumn 160, Issue 1, 2009, Pages 215-217
|
Haber's syndrome may be a clinical entity different from Dowling-Degos disease
|
Author keywords
Dowling Degos disease; Genodermatosis; Haber syndrome; Keratin 5
|
Indexed keywords
CYTOKERATIN 5;
FIBROBLAST GROWTH FACTOR RECEPTOR 3;
PHOSPHATIDYLINOSITOL 3 KINASE;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
DNA POLYMORPHISM;
GENE MUTATION;
GENETIC ANALYSIS;
GENODERMATOSIS;
HABER SYNDROME;
HISTOPATHOLOGY;
HUMAN;
LETTER;
LOSS OF FUNCTION MUTATION;
MALIGNANT ATROPHIC PAPULOSIS;
PATHOGENESIS;
PRIORITY JOURNAL;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
AGED;
CHROMOSOME DISORDERS;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
HYPERPIGMENTATION;
KERATIN-5;
KERATOSIS, SEBORRHEIC;
PEDIGREE;
RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;
SKIN DISEASES;
SYNDROME;
TREATMENT OUTCOME;
|
EID: 57649215229
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2008.08938.x Document Type: Letter |
Times cited : (8)
|
References (10)
|